GlassScriptPhysician profile
Lindsey Van
NPI 1811587892
$1,907.54
in general payments reported to CMS, 2019-2025
20 companies · $687 in 2025
The $687 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.33 · 2022: $489 · 2023: $259 · 2024: $386 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $364.14 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $221.32 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $205.40 | 2022-2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $182.80 | 2021-2023 | Cequa |
| Alcon Vision LLC | $171.32 | 2022-2025 | Tryptyr, Rocklatan, Eysuvis |
| Allergan, INC. | $144.87 | 2022 | |
| Dompe US, INC. | $115.15 | 2022-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $71.63 | 2023 | |
| Abbvie INC. | $67.75 | 2024-2025 | |
| Heru, INC. | $66.31 | 2022 | |
| Coopervision INC. | $56.02 | 2022-2025 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $52.61 | 2022-2023 | Acuvue |
| Mallinckrodt Hospital Products INC. | $45.64 | 2024-2025 | Acthar |
| Amgen INC. | $34.22 | 2024-2025 | Tepezza |
| Harrow Eye, LLC | $26.97 | 2025 | Vevye |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.02 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $17.43 | 2022 | |
| Biotissue Holdings INC. | $14.51 | 2022 | |
| Rxsight INC | $13.93 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Glaukos Corporation | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.